QGEN(Qiagen N.V.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.25B | $2.14B | $1.97B | $1.98B | $2.09B |
| 毛利润 | $1.45B | $1.38B | $1.23B | $967.35M | $1.30B |
| 营业利润 | $630.08M | $531.46M | $409.94M | $97.71M | $465.85M |
| 净利润 | $512.60M | $423.21M | $341.30M | $83.59M | $424.88M |
| 经营现金流 | $639.00M | $715.26M | $459.45M | $673.55M | $654.33M |
| 自由现金流 | $449.10M | $586.04M | $309.75M | $506.38M | $453.28M |
| 摊薄每股收益 | $2.21 | $1.84 | $1.48 | $0.37 | $1.94 |